Ovid Therapeutics Inc. (FRA:1OT)

Ovid Therapeutics Statistics

Total Valuation

FRA:1OT has a market cap or net worth of EUR 110.26 million. The enterprise value is 100.08 million.

Market Cap	110.26M
Enterprise Value	100.08M

Important Dates

The next estimated earnings date is Wednesday, March 11, 2026.

Earnings Date	Mar 11, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	71.21M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	5.53%
Owned by Institutions (%)	36.57%
Float	59.74M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	19.57
PB Ratio	2.89
P/TBV Ratio	2.89
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-3.27
EV / Sales	17.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.09

Financial Position

The company has a current ratio of 4.24, with a Debt / Equity ratio of 0.31.

Current Ratio	4.24
Quick Ratio	3.77
Debt / Equity	0.31
Debt / EBITDA	n/a
Debt / FCF	-0.36
Interest Coverage	-18.73

Financial Efficiency

Return on equity (ROE) is -60.06% and return on invested capital (ROIC) is -32.59%.

Return on Equity (ROE)	-60.06%
Return on Assets (ROA)	-29.33%
Return on Invested Capital (ROIC)	-32.59%
Return on Capital Employed (ROCE)	-68.48%
Revenue Per Employee	244,944
Profits Per Employee	-1.33M
Employee Count	23
Asset Turnover	0.08
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +45.55% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+45.55%
50-Day Moving Average	1.25
200-Day Moving Average	0.63
Relative Strength Index (RSI)	65.30
Average Volume (20 Days)	35

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	1.23

Income Statement

In the last 12 months, FRA:1OT had revenue of EUR 5.63 million and -30.57 million in losses. Loss per share was -0.43.

Revenue	5.63M
Gross Profit	5.63M
Operating Income	-33.30M
Pretax Income	-30.96M
Net Income	-30.57M
EBITDA	-32.94M
EBIT	-33.30M
Loss Per Share	-0.43

Balance Sheet

The company has 21.82 million in cash and 11.73 million in debt, giving a net cash position of 10.09 million.

Cash & Cash Equivalents	21.82M
Total Debt	11.73M
Net Cash	10.09M
Net Cash Per Share	n/a
Equity (Book Value)	38.10M
Book Value Per Share	0.54
Working Capital	18.77M

Cash Flow

In the last 12 months, operating cash flow was -32.33 million and capital expenditures -18,751, giving a free cash flow of -32.35 million.

Operating Cash Flow	-32.33M
Capital Expenditures	-18,751
Free Cash Flow	-32.35M
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-591.04%
Pretax Margin	-549.62%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:1OT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	-0.35%
Earnings Yield	-27.73%
FCF Yield	-29.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:1OT has an Altman Z-Score of -7.14 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.14
Piotroski F-Score	1